These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3063172)

  • 1. Isolation and characterization of fluoropyrimidine-resistant mutants in two Candida species.
    Fasoli M; Kerridge D
    Ann N Y Acad Sci; 1988; 544():260-3. PubMed ID: 3063172
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sensitivity and resistance of Candida to 5-fluorocytosine, 5-fluorouracil and 5-fluorouridine. Relation to the ecology and serotype of C. albicans].
    Drouhet E; Mercier-Soucy L; Montplaisir S
    C R Acad Hebd Seances Acad Sci D; 1974 Jan; 278(5):605-8. PubMed ID: 4211641
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug resistance in Candida albicans and Candida glabrata.
    Kerridge D; Fasoli M; Wayman FJ
    Ann N Y Acad Sci; 1988; 544():245-59. PubMed ID: 3063171
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sensitivity and resistance of pathogenic yeasts to 5-fluoropyrimidines. I.--Relation between the phenotypes of resistance to 5-fluorocytosine, the serotype of Candida albicans and the ecology of various species of Candida of human origin (author's transl)].
    Drouhet E; Mercier-Soucy L; Montplaisir S
    Ann Microbiol (Paris); 1975; 126B(1):25-39. PubMed ID: 1108732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 19F nuclear magnetic resonance study of fluoropyrimidine metabolism in strains of Candida glabrata with specific defects in pyrimidine metabolism.
    Fasoli MO; Kerridge D; Morris PG; Torosantucci A
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1996-2006. PubMed ID: 2291666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induction of resistance of yeast-like fungi to synthetic antifungal agents].
    Pawlik B; Hołuj-Gubała J; Dźwigaj-Stokłosa W
    Med Dosw Mikrobiol; 1983; 35(1):43-8. PubMed ID: 6633032
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenicity of 5-fluorocytosine resistant strains of Candida albicans.
    Fasoli MO; Kerridge D; Ryley JF
    J Med Vet Mycol; 1990; 28(1):27-34. PubMed ID: 2194016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.
    Normark S; Schönebeck J
    Antimicrob Agents Chemother; 1972 Sep; 2(3):114-21. PubMed ID: 4597703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance.
    Papon N; Noël T; Florent M; Gibot-Leclerc S; Jean D; Chastin C; Villard J; Chapeland-Leclerc F
    Antimicrob Agents Chemother; 2007 Jan; 51(1):369-71. PubMed ID: 17060521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [C. albicans spontaneous mutations determining 5-fluorocytosine resistance].
    Pawlik B; Barylak J
    Med Dosw Mikrobiol; 1977; 29(4):301-7. PubMed ID: 340821
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenotypes of resistance to fluorophyrimidines and the occurence of 5-fluorocytosine resistant mutants in Candida and Torulopsis yeasts.
    Pawlik B; Barylak J
    Mykosen; 1978 Nov; 21(11):377-81. PubMed ID: 570245
    [No Abstract]   [Full Text] [Related]  

  • 12. Segregation of 5-fluorocytosine-resistance variants by Candida albicans.
    Whelan WL; Beneke ES; Rogers AL; Soll DR
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1078-81. PubMed ID: 7023383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The susceptibility of Candida albicans strains to selected anticancer drugs and flucytosine, relevance of the presence of self-splicing intron in 25S rDNA.
    Król J; Nawrot U; Bartoszewicz M
    J Mycol Med; 2019 Apr; 29(1):39-43. PubMed ID: 30545669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity in vitro of opportunist yeasts (Candida albicans and Torulopsis glabrata) to flucytosine and concordance curves (author's transl)].
    Slim A; Bergogne-Berezin E; Courtoux D
    Ann Biol Clin (Paris); 1978; 36(2):69-74. PubMed ID: 358866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates.
    Defever KS; Whelan WL; Rogers AL; Beneke ES; Veselenak JM; Soll DR
    Antimicrob Agents Chemother; 1982 Nov; 22(5):810-5. PubMed ID: 6758690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrata.
    Kerridge D; Nicholas RO
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():39-49. PubMed ID: 3539907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilocus sequence typing confirms synonymy but highlights differences between Candida albicans and Candida stellatoidea.
    Jacobsen MD; Boekhout T; Odds FC
    FEMS Yeast Res; 2008 Aug; 8(5):764-70. PubMed ID: 18547330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementation analysis of resistance to 5-fluorocytosine in Candida albicans.
    Whelan WL; Markie D; Kwon-Chung KJ
    Antimicrob Agents Chemother; 1986 May; 29(5):726-9. PubMed ID: 3524427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Fluorocytosine and Candida yeasts.
    Fabbri A; Tacchella A; Belli ML; Toriello E
    Chemioterapia; 1987 Feb; 6(1):8-11. PubMed ID: 3549011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoconazole and flucytosine alone and in combination against Candida spp. in a neutropenic site in rabbits.
    Hughes CE; Peterson LR; Beggs WH; Gerding DN
    J Antimicrob Chemother; 1986 Jul; 18(1):65-72. PubMed ID: 3531144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.